J.W. Cole Advisors Inc. boosted its holdings in shares of The Sherwin-Williams Company (NYSE:SHW - Free Report) by 571.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,630 shares of the specialty chemicals company's stock after buying an additional 7,344 shares during the quarter. J.W. Cole Advisors Inc.'s holdings in Sherwin-Williams were worth $3,014,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. BKM Wealth Management LLC lifted its stake in shares of Sherwin-Williams by 61.7% in the first quarter. BKM Wealth Management LLC now owns 2,621 shares of the specialty chemicals company's stock valued at $915,000 after buying an additional 1,000 shares during the period. OneAscent Financial Services LLC grew its holdings in Sherwin-Williams by 86.5% during the 1st quarter. OneAscent Financial Services LLC now owns 4,432 shares of the specialty chemicals company's stock worth $1,552,000 after acquiring an additional 2,055 shares during the period. Copperwynd Financial LLC lifted its position in Sherwin-Williams by 7.8% during the 1st quarter. Copperwynd Financial LLC now owns 2,954 shares of the specialty chemicals company's stock worth $1,031,000 after buying an additional 214 shares in the last quarter. Kestra Private Wealth Services LLC boosted its position in shares of Sherwin-Williams by 3.4% during the 1st quarter. Kestra Private Wealth Services LLC now owns 10,703 shares of the specialty chemicals company's stock worth $3,737,000 after acquiring an additional 348 shares in the last quarter. Finally, Diversify Advisory Services LLC raised its stake in Sherwin-Williams by 77.5% during the first quarter. Diversify Advisory Services LLC now owns 1,280 shares of the specialty chemicals company's stock worth $446,000 after buying an additional 559 shares during the last quarter. 77.67% of the stock is owned by institutional investors and hedge funds.
Sherwin-Williams Price Performance
Shares of SHW stock opened at $342.34 on Tuesday. The stock has a 50 day moving average of $349.79 and a two-hundred day moving average of $348.09. The Sherwin-Williams Company has a 12 month low of $308.84 and a 12 month high of $400.42. The company has a market capitalization of $85.79 billion, a P/E ratio of 32.36, a P/E/G ratio of 3.06 and a beta of 1.18. The company has a current ratio of 0.77, a quick ratio of 0.45 and a debt-to-equity ratio of 1.90.
Sherwin-Williams (NYSE:SHW - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The specialty chemicals company reported $3.38 EPS for the quarter, missing analysts' consensus estimates of $3.75 by ($0.37). Sherwin-Williams had a net margin of 11.63% and a return on equity of 71.86%. As a group, equities analysts expect that The Sherwin-Williams Company will post 12 EPS for the current year.
Sherwin-Williams Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 15th will be given a dividend of $0.79 per share. The ex-dividend date is Friday, August 15th. This represents a $3.16 annualized dividend and a yield of 0.92%. Sherwin-Williams's payout ratio is 29.87%.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on SHW shares. Bank of America increased their price target on shares of Sherwin-Williams from $289.00 to $296.00 and gave the company an "underperform" rating in a research report on Monday, June 23rd. UBS Group increased their target price on shares of Sherwin-Williams from $398.00 to $410.00 and gave the stock a "buy" rating in a report on Wednesday, July 9th. Citigroup lowered shares of Sherwin-Williams from a "buy" rating to a "neutral" rating and decreased their target price for the company from $405.00 to $385.00 in a report on Friday, June 13th. Morgan Stanley cut their price objective on Sherwin-Williams from $405.00 to $385.00 and set an "overweight" rating for the company in a research report on Tuesday, April 22nd. Finally, Mizuho set a $395.00 price objective on Sherwin-Williams in a report on Tuesday, April 15th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Sherwin-Williams has a consensus rating of "Moderate Buy" and an average target price of $391.94.
Read Our Latest Stock Analysis on SHW
Sherwin-Williams Company Profile
(
Free Report)
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sherwin-Williams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sherwin-Williams wasn't on the list.
While Sherwin-Williams currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.